Efficacy and Safety of TF002 in Cutaneous Mastocytosis
NCT00457288
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Cutaneous Mastocytosis
Interventions
DRUG:
TF 002
Sponsor
JADO Technologies GmbH